iHuman (NYSE:IH – Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.07 EPS for the quarter, Zacks reports. iHuman had a net margin of 10.69% and a return on equity of 10.57%.
iHuman Price Performance
Shares of NYSE IH opened at $2.38 on Thursday. The stock has a market capitalization of $123.81 million, a PE ratio of 9.15 and a beta of 0.36. The firm has a fifty day moving average of $2.26 and a 200-day moving average of $2.05. iHuman has a 52-week low of $1.47 and a 52-week high of $3.18.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in iHuman stock. Acadian Asset Management LLC bought a new position in shares of iHuman Inc. Sponsored ADR (NYSE:IH – Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The fund bought 15,067 shares of the company’s stock, valued at approximately $32,000. 4.92% of the stock is owned by institutional investors and hedge funds.
About iHuman
iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.
Further Reading
- Five stocks we like better than iHuman
- What is the Dogs of the Dow Strategy? Overview and Examples
- Deere & Co.: A Quiet Industrial Leader Gaining Steam
- Comparing and Trading High PE Ratio Stocks
- Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst
- How to Use the MarketBeat Stock Screener
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
Receive News & Ratings for iHuman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iHuman and related companies with MarketBeat.com's FREE daily email newsletter.